Preclinical Evaluation of Trastuzumab Deruxtecan (T-DXd) Reveals Apoptosis and Bystander Killing in HER2-Altered Cholangiocarcinoma

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Prin Sungwan, Jutatip Panaampon, Ratchaneewan Sumankan, Sawako Fujikawa, Seiji Okada
DOI: 10.2139/ssrn.6295941
Cited by: 0

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies HER2/EGFR in Cancer Research Gallbladder and Bile Duct Disorders

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Language
EN
Document type
Preprint